Rising drug costs: Greenlife unveils new strategy, eyes local production
The company’s new initiative, Pharmacy Access and Commercial Trade, PACT 2026, was launched at its inaugural forum in Lagos, bringing together major wholesalers and trade partners to discuss sustainable growth, business institutionalisation and stronger commercial relationships.
By Chioma Obinna Amid rising costs of pharmaceutical raw materials and growing pressure on the drug industry, Greenlife Pharmaceuticals Limited has unveiled a new strategy to strengthen partnerships across the pharmaceutical value chain and advance plans for local manufacturing.
Speaking on “Sustainable Pharma Access and Commercial Trade through Institutionalization,” the company’s Corporate Performance and Strategy representative, Mr Jones Ekwealor, challenged trade partners to build businesses that could survive beyond their founders.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
